Dr. Charles E. Geyer Jr., MD

Dr. Geyer practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Geyer's NPI, 1891795001, was assigned on July 29, 2005. Dr. Geyer graduated from Texas Tech University Health Sciences Center School of Medicine in 1980. Dr. Geyer's Texas license number on file is F6662.

Dr. Geyer's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Geyer's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Geyer is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Geyer to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geyer practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Geyer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Geyer is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Geyer's licenses on file in 4 states: Texas, Pennsylvania, Virginia and Florida.

Dmand AI lists breast cancer among the conditions Dr. Geyer treats.

CMS data shows 27 Medicare services from Dr. Geyer across 1 procedure code in 2021, all of them office visits, for 13 Medicare patients. Medicare paid $2,799 for them. Every service was in an office.

CMS counts 13 Medicare patients who saw Dr. Geyer in 2024. 75% of them have cancer. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Geyer's median patient age at 67, with 100% women.

In 2024, Dr. Geyer wrote 94 Medicare Part D claims for 18 patients. 98% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $1,244 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Geyer for performance year 2024, reported as part of a group. Dr. Geyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 86 papers to Dr. Geyer, published from 2006 to 2024. 2014 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Chemotherapy, Adjuvant. Dr. Geyer has published most often in J Clin Oncol. Dr. Geyer's most frequent co-authors are Eleftherios P. Mamounas, MD, Norman Wolmark, MD and Louis Fehrenbacher, MD.

Dmand AI links Dr. Geyer to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 140 general payments to Dr. Geyer from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 45% of the total. Genentech, Inc. paid the most, $66,360. It also lists 25 research payments totaling $24,050 from 2016 to 2025.

Dmand AI lists 1 award for Dr. Geyer, most recently CMS Stage 1 EHR in 2012.

Dr. Geyer graduated from Texas Tech University Health Sciences Center School of Medicine in 1980. Dr. Geyer is a member of ASCO.

Dr. Geyer is in network with 6 carriers, including Aetna, Highmark and Elevance. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.